SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin trades higher on the bourses

15 Feb 2021 Evaluate

Lupin is currently trading at Rs. 1061.35, up by 8.90 points or 0.85% from its previous closing of Rs. 1052.45 on the BSE.

The scrip opened at Rs. 1059.80 and has touched a high and low of Rs. 1074.55 and Rs. 1051.45 respectively. So far 78174 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1121.85 on 18-Sep-2020 and a 52 week low of Rs. 505.00 on 13-Mar-2020.

Last one week high and low of the scrip stood at Rs. 1086.95 and Rs. 1048.05 respectively. The current market cap of the company is Rs. 48308.49 crore.

The promoters holding in the company stood at 46.88%, while Institutions and Non-Institutions held 40.05% and 12.79% respectively.

Lupin’s wholly-owned subsidiary -- Lupin Pharmaceuticals Inc, is recalling 46,479 bottles of anti-viral medication Oseltamivir Phosphate for Oral Suspension in the American market. The company has initiated the recall of the affected lot due to ‘Failed Impurities/Degradation Specifications’. The product has been manufactured at Lupin's Aurangabad (Maharashtra) based manufacturing plant. The company initiated the recall, which the US health regulator has classified as Class III, on January 21 this year.

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India.

Lupin Share Price

2322.50 -4.00 (-0.17%)
17-Apr-2026 11:13 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1680.00
Dr. Reddys Lab 1223.05
Cipla 1240.50
Zydus Lifesciences 945.70
Lupin 2322.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×